Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

Por Röth, Alexander, Bommer, Martin, Hüttmann, Andreas, Herich-Terhürne, Dörte, Kuklik, Nils, Rekowski, Jan, Lenz, Veronika, Schrezenmeier, Hubert, Dührsen, Ulrich
Publicado no Blood Adv (2018)

Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination

Por Schmitz, Christine, Hüttmann, Andreas, Müller, Stefan P., Hanoun, Maher, Boellaard, Ronald, Brinkmann, Marcus, Jöckel, Karl-Heinz, Dührsen, Ulrich, Rekowski, Jan
Publicado no Data Brief (2019)

Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma

Por Wagner, Bettina, Dührsen, Ulrich, Hüttmann, Andreas, Nückel, Holger, Michita, Rafael Tomoya, Rohn, Hana, Schramm, Sabine, Horn, Peter A., Rebmann, Vera
Publicado no Cancers (Basel) (2020)

Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia

Por Hanoun, Maher, Eisele, Lewin, Suzuki, Masako, Greally, John M., Hüttmann, Andreas, Aydin, Semra, Scholtysik, René, Klein-Hitpass, Ludger, Dührsen, Ulrich, Dürig, Jan
Publicado em 2012

Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia

Por Göbel, Maria, Eisele, Lewin, Möllmann, Michael, Hüttmann, Andreas, Johansson, Patricia, Scholtysik, René, Bergmann, Manuela, Busch, Raymonde, Döhner, Hartmut, Hallek, Michael, Seiler, Till, Stilgenbauer, Stephan, Klein-Hitpass, Ludger, Dührsen, Ulrich, Dürig, Jan
Publicado em 2013

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with in...

Por Richter, Julia, Hüttmann, Andreas, Rekowski, Jan, Schmitz, Christine, Gärtner, Selina, Rosenwald, Andreas, Hansmann, Martin-Leo, Hartmann, Sylvia, Möller, Peter, Wacker, Hans-Heinrich, Feller, Alfred, Thorns, Christoph, Müller, Stefan, Dührsen, Ulrich, Klapper, Wolfram
Publicado no Blood Cancer J (2019)

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy

Por Schmitz, Christine, Rekowski, Jan, Müller, Stefan P., Farsijani, Navid, Hertenstein, Bernd, Franzius, Christiane, von Verschuer, Ulla, La Rosée, Paul, Freesmeyer, Martin, Wilop, Stefan, Krohn, Thomas, Raghavachar, Aruna, Ganser, Arnold, Bengel, Frank M., Prange‐Krex, Gabriele, Kroschinsky, Frank, Kotzerke, Jörg, Giagounidis, Aristoteles, Dührsen, Ulrich, Hüttmann, Andreas
Publicado no Cancer Med (2020)

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial

Por Bröckelmann, Paul J., Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V., Sasse, Stephanie, Sökler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Hüttmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter, Engert, Andreas
Publicado no JAMA Oncol (2020)

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Por Hoelzer, Dieter, Walewski, Jan, Döhner, Hartmut, Viardot, Andreas, Hiddemann, Wolfgang, Spiekermann, Karsten, Serve, Hubert, Dührsen, Ulrich, Hüttmann, Andreas, Thiel, Eckhard, Dengler, Jolanta, Kneba, Michael, Schaich, Markus, Schmidt-Wolf, Ingo G. H., Beck, Joachim, Hertenstein, Bernd, Reichle, Albrecht, Domanska-Czyz, Katarzyna, Fietkau, Rainer, Horst, Heinz-August, Rieder, Harald, Schwartz, Stefan, Burmeister, Thomas, Gökbuget, Nicola
Publicado no Blood (2014)

Dynamic risk profiling using serial tumor biomarkers for personalized outcome Prediction

Por Kurtz, David M., Esfahani, Mohammad S., Scherer, Florian, Soo, Joanne, Jin, Michael C., Liu, Chih Long, Newman, Aaron M., Dührsen, Ulrich, Hüttmann, Andreas, Casasnovas, Olivier, Westin, Jason R., Ritgen, Matthais, Böttcher, Sebastian, Langerak, Anton W., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Bahlo, Jasmin, Hallek, Michael, Tibshirani, Robert, Diehn, Maximilian, Alizadeh, Ash A.
Publicado no Cell (2019)

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

Por Kurtz, David M., Scherer, Florian, Jin, Michael C., Soo, Joanne, Craig, Alexander F.M., Esfahani, Mohammad Shahrokh, Chabon, Jacob J., Stehr, Henning, Liu, Chih Long, Tibshirani, Robert, Maeda, Lauren S., Gupta, Neel K., Khodadoust, Michael S., Advani, Ranjana H., Levy, Ronald, Newman, Aaron M., Dührsen, Ulrich, Hüttmann, Andreas, Meignan, Michel, Casasnovas, René-Olivier, Westin, Jason R., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.
Publicado no J Clin Oncol (2018)

Brentuximab Vedotin with Chemotherapy for CD30-Positive Peripheral T-cell Lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Por Horwitz, Steven, O’Connor, Owen A, Pro, Barbara, Illidge, Tim, Fanale, Michelle, Advani, Ranjana, Bartlett, Nancy L, Christensen, Jacob Haaber, Morschhauser, Franck, Domingo-Domenech, Eva, Rossi, Giuseppe, Kim, Won Seog, Feldman, Tatyana, Lennard, Anne, Belada, David, Illès, Árpád, Tobinai, Kensei, Tsukasaki, Kunihiro, Yeh, Su-Peng, Shustov, Andrei, Hüttmann, Andreas, Savage, Kerry J, Yuen, Sam, Iyer, Swaminathan, Zinzani, Pier Luigi, Hua, Zhaowei, Little, Meredith, Rao, Shangbang, Woolery, Joseph, Manley, Thomas, Trümper, Lorenz
Publicado no Lancet (2018)